Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-20

Clinical Trial Update: Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on intermittent pneumatic compression therapy for head and neck cancer-related lymphedema (Phases 1 and 2) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intermittent pneumatic compression therapy

Snippet

Sponsor: Tactile Medical | Conditions: Head and Neck Neoplasms, Head and Neck Lymphedema | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-03-20